Loading company…
Mabvax Therapeutics, Inc., based in San Diego, US, develops antibody-based cancer therapies.
Founded in 2006 and headquartered in San Diego, US, Mabvax Therapeutics, Inc. is a biotechnology company developing antibody-based cancer therapies. It underwent a merger with Telik in May 2014 that resulted in its public listing. CEO David Hansen leads the company. It has engaged in 12 deals, raising USD 11.61 mn across its rounds, with the latest in 2014. In 2017 it reported zero revenue and an EBITDA loss of USD 17,516,791.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in